ADH1 and ADH2 Disease Monitoring Study (DMS)

Clinical trial NCT05227287 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05227287
Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Autosomal Dominant Hypocalcemia

Start date: 2022-01-20
Primary completion: 2028-11-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.